omega-n-methylarginine has been researched along with Disease Exacerbation in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 6 (54.55) | 29.6817 |
2010's | 3 (27.27) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Doğan, Ö; Haşimi, A; Serdar, CC; Serdar, MA | 1 |
Bode-Böger, SM; Emrich, IE; Fliser, D; Heine, GH; Martens-Lobenhoffer, J; Wagenpfeil, S; Zawada, AM | 1 |
Jang, SJ; Kang, JH; Lee, J; Lee, JW; Lee, MH; Moon, EY; Ryu, YK | 1 |
Bachmann, S; Chander, P; Goligorsky, MS; Jasmin, JF; Lisanti, MP; Park, HC; Ratliff, B; Sharkovska, Y; Stoessel, A; Yamamoto, I; Yasuda, K | 1 |
Cowden, WB; de Haan, JB; Dinauer, M; Hunt, NH; Mitchell, AJ; Potter, SM; Sanni, LA | 1 |
Hong, CY; Hsiao, M; Kok, SH; Kuo, MY; Lin, CT; Lin, LD; Lin, SK; Wang, CC | 1 |
de la Torre, E; Español, AJ; Fiszman, GL; Sales, ME | 1 |
Schmidt, BM | 1 |
Hamano, M; Mashiko, S; Onda, T; Tomita, I; Tomita, T | 1 |
Cave, AC; Gall, NP; Grieve, DJ; MacCarthy, PA; Shah, AM | 1 |
Hashimoto, M; Inoue, S; Ishibashi, Y; Katoh, H; Murakami, Y; Nakamura, K; Ohata, S; Ohta, Y; Sakane, T; Shimada, T; Shimizu, H; Sugamori, T; Takahashi, N | 1 |
1 review(s) available for omega-n-methylarginine and Disease Exacerbation
Article | Year |
---|---|
Rapid non-genomic effects of aldosterone on the renal vasculature.
Topics: Aldosterone; Animals; Blood Flow Velocity; Disease Progression; Endothelium, Vascular; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Male; Models, Biological; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Rabbits | 2008 |
10 other study(ies) available for omega-n-methylarginine and Disease Exacerbation
Article | Year |
---|---|
Association of serum ADMA, SDMA and L-NMMA concentrations with disease progression in COVID-19 patients.
Topics: Arginine; COVID-19; Disease Progression; Humans; omega-N-Methylarginine | 2023 |
Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Chromatography, Liquid; Disease Progression; Female; Germany; Humans; Incidence; Male; Middle Aged; omega-N-Methylarginine; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2018 |
γ-Irradiated cancer cells promote tumor growth by activation of Toll-like receptor 1-mediated inducible nitric oxide synthase in macrophages.
Topics: 3T3 Cells; Adenocarcinoma; Animals; Bone Marrow Cells; Cell Line, Tumor; Chlorocebus aethiops; Coculture Techniques; Colonic Neoplasms; COS Cells; Disease Progression; Enzyme Induction; Gamma Rays; Macrophages; Macrophages, Peritoneal; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Neoplasm Proteins; Nitric Oxide; Nitric Oxide Synthase Type II; omega-N-Methylarginine; Recurrence; Toll-Like Receptor 1; Tumor Microenvironment | 2015 |
Postobstructive regeneration of kidney is derailed when surge in renal stem cells during course of unilateral ureteral obstruction is halted.
Topics: Animals; Benzylamines; Caveolin 1; Cell Division; Chemokine CXCL12; Cyclams; Disease Progression; Enzyme Inhibitors; Fibrosis; Hematopoietic Stem Cells; Heterocyclic Compounds; Kidney; Kidney Cortex; Male; Mesenchymal Stem Cells; Mice; Mice, Inbred Strains; Nitric Oxide Synthase; omega-N-Methylarginine; Receptors, CXCR4; Recovery of Function; Regeneration; Stem Cells; Ureteral Obstruction | 2010 |
Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections.
Topics: Animals; Disease Progression; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Immune System; Malaria; Mice; Mice, Inbred C57BL; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Phagocytes; Plasmodium berghei; Reactive Oxygen Species | 2005 |
Nitric oxide promotes the progression of periapical lesion via inducing macrophage and osteoblast apoptosis.
Topics: Animals; Apoptosis; Cell Line; Cells, Cultured; Disease Models, Animal; Disease Progression; Drug Synergism; Enzyme Inhibitors; Free Radical Scavengers; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase Type II; Nitrites; omega-N-Methylarginine; Osteoblasts; Periapical Diseases; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Rats; Rats, Wistar; RNA, Small Interfering; S-Nitroso-N-Acetylpenicillamine | 2007 |
Role of non-neuronal cholinergic system in breast cancer progression.
Topics: Animals; Arginase; Carbachol; Cell Line, Tumor; Cholinergic Agonists; Cyclooxygenase Inhibitors; Disease Progression; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Neurons; Nitric Oxide Synthase Type I; Nitrobenzenes; omega-N-Methylarginine; Prostaglandin-Endoperoxide Synthases; Receptor, Muscarinic M1; Receptor, Muscarinic M2; Receptors, Cholinergic; Sulfonamides | 2007 |
Blood pressure-related changes of endothelium-dependent relaxation in the aorta from SHRSP at developmental ages of hypertension.
Topics: Aging; Animals; Aorta, Thoracic; Blood Pressure; Disease Progression; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1995 |
Divergent biological actions of coronary endothelial nitric oxide during progression of cardiac hypertrophy.
Topics: Animals; Disease Progression; Endothelium, Vascular; Enzyme Inhibitors; Guinea Pigs; Heart; Hypertrophy, Left Ventricular; Male; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Organ Culture Techniques; Organ Size; Vasoconstriction; Vasodilation; Vasodilator Agents; Ventricular Pressure | 2001 |
An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure.
Topics: Acetylcholine; Adult; Aged; Analysis of Variance; Atrial Natriuretic Factor; Blood Flow Velocity; Case-Control Studies; Disease Progression; Dose-Response Relationship, Drug; Drug Monitoring; Endothelium, Vascular; Female; Forearm; Guanidines; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Plethysmography; Severity of Illness Index; Time Factors; Vasodilation | 2001 |